-
1
-
-
38949210220
-
Effect of a multifactorial intervention on mortality in type 2 diabetes
-
COI: 1:CAS:528:DC%2BD1cXhs1entLc%3D, PID: 18256393
-
Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008;358:580–591.
-
(2008)
N Engl J Med
, vol.358
, pp. 580-591
-
-
Gaede, P.1
Lund-Andersen, H.2
Parving, H.H.3
Pedersen, O.4
-
2
-
-
33645276928
-
Projecting the number of patients with end-stage renal disease in the United States to the year 2015
-
PID: 16267160
-
Gilbertson DT, Liu J, Xue JL, Louis TA, Solid CA, Ebben JP, et al. Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol 2005;16:3736–3741.
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 3736-3741
-
-
Gilbertson, D.T.1
Liu, J.2
Xue, J.L.3
Louis, T.A.4
Solid, C.A.5
Ebben, J.P.6
-
3
-
-
0035922444
-
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
-
COI: 1:CAS:528:DC%2BD3MXntlelsLY%3D, PID: 11565519
-
Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001;345:870–878.
-
(2001)
N Engl J Med
, vol.345
, pp. 870-878
-
-
Parving, H.H.1
Lehnert, H.2
Brochner-Mortensen, J.3
Gomis, R.4
Andersen, S.5
Arner, P.6
-
4
-
-
84860273272
-
Proteinuria should be used as a surrogate in CKD
-
COI: 1:CAS:528:DC%2BC38Xmt1Giurk%3D, PID: 22391456
-
Cravedi P, Ruggenenti P, Remuzzi G. Proteinuria should be used as a surrogate in CKD. Nat Rev Nephrol 2012;8:301–306.
-
(2012)
Nat Rev Nephrol
, vol.8
, pp. 301-306
-
-
Cravedi, P.1
Ruggenenti, P.2
Remuzzi, G.3
-
5
-
-
79953053474
-
Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials
-
COI: 1:CAS:528:DC%2BC3MXnvFamsrw%3D, PID: 21421598
-
Holtkamp FA, de Zeeuw D, de Graeff PA, Laverman GD, Berl T, Remuzzi G, et al. Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials. Eur Heart J 2011;32:1493–1499.
-
(2011)
Eur Heart J
, vol.32
, pp. 1493-1499
-
-
Holtkamp, F.A.1
de Zeeuw, D.2
de Graeff, P.A.3
Laverman, G.D.4
Berl, T.5
Remuzzi, G.6
-
6
-
-
4344621497
-
Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy
-
PID: 15302780
-
de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 2004;110:921–927.
-
(2004)
Circulation
, vol.110
, pp. 921-927
-
-
de Zeeuw, D.1
Remuzzi, G.2
Parving, H.H.3
Keane, W.F.4
Zhang, Z.5
Shahinfar, S.6
-
7
-
-
0035922441
-
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
-
COI: 1:CAS:528:DC%2BD3MXntlelsLk%3D, PID: 11565518
-
Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001;345:861–869.
-
(2001)
N Engl J Med
, vol.345
, pp. 861-869
-
-
Brenner, B.M.1
Cooper, M.E.2
de Zeeuw, D.3
Keane, W.F.4
Mitch, W.E.5
Parving, H.H.6
-
8
-
-
0035922447
-
Renoprotective effect of the angiotensinreceptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
-
COI: 1:CAS:528:DC%2BD3MXntlelsLg%3D, PID: 11565517
-
Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al. Renoprotective effect of the angiotensinreceptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001;345:851–860.
-
(2001)
N Engl J Med
, vol.345
, pp. 851-860
-
-
Lewis, E.J.1
Hunsicker, L.G.2
Clarke, W.R.3
Berl, T.4
Pohl, M.A.5
Lewis, J.B.6
-
9
-
-
32444451549
-
Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes
-
COI: 1:CAS:528:DC%2BD28Xht1Sru70%3D, PID: 16453013
-
Remuzzi G, Benigni A, Remuzzi A. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 2006;116:288–296.
-
(2006)
J Clin Invest
, vol.116
, pp. 288-296
-
-
Remuzzi, G.1
Benigni, A.2
Remuzzi, A.3
-
10
-
-
84866656037
-
Glomerular hyperfiltration and renal disease progression in type 2 diabetes
-
COI: 1:CAS:528:DC%2BC38Xhs1Gks7%2FJ, PID: 22773704
-
Ruggenenti P, Porrini EL, Gaspari F, Motterlini N, Cannata A, Carrara F, et al. Glomerular hyperfiltration and renal disease progression in type 2 diabetes. Diabetes Care 2012;35:2061–2068.
-
(2012)
Diabetes Care
, vol.35
, pp. 2061-2068
-
-
Ruggenenti, P.1
Porrini, E.L.2
Gaspari, F.3
Motterlini, N.4
Cannata, A.5
Carrara, F.6
-
11
-
-
84855175926
-
Effects of Panax notoginoside on the nephropathy in rats with type 1 diabetes mellitus
-
PID: 21826596
-
Tu QN, Dong H, Lu FE. Effects of Panax notoginoside on the nephropathy in rats with type 1 diabetes mellitus. Chin J Integr Med 2011;17:612–615.
-
(2011)
Chin J Integr Med
, vol.17
, pp. 612-615
-
-
Tu, Q.N.1
Dong, H.2
Lu, F.E.3
-
13
-
-
84884409558
-
Colon may provide new therapeutic targets for treatment of chronic kidney disease with Chinese medicine
-
COI: 1:CAS:528:DC%2BC3sXitVOjtL0%3D, PID: 23371456
-
Zou C, Lu ZY, Wu YC, Yang LH, Su GB, Jie XN, et al. Colon may provide new therapeutic targets for treatment of chronic kidney disease with Chinese medicine. Chin J Integr Med 2013;19:86–91.
-
(2013)
Chin J Integr Med
, vol.19
, pp. 86-91
-
-
Zou, C.1
Lu, Z.Y.2
Wu, Y.C.3
Yang, L.H.4
Su, G.B.5
Jie, X.N.6
-
14
-
-
84862743353
-
The theory of homogeny of Liver and Kidney in the treatment of kidney and liver fibrosis
-
PID: 22457134
-
Li P, Zhang HJ, Zheng LT. The theory of homogeny of Liver and Kidney in the treatment of kidney and liver fibrosis. Chin J Integr Med 2012;18:250–252.
-
(2012)
Chin J Integr Med
, vol.18
, pp. 250-252
-
-
Li, P.1
Zhang, H.J.2
Zheng, L.T.3
-
15
-
-
75649131148
-
Fast and automated characterization of major constituents in rat biofluid after oral administration of Abelmoschus manihot extract using ultra-performance liquid chromatography/quadrupole time-offlight mass spectrometry and MetaboLynx
-
COI: 1:CAS:528:DC%2BC3cXos1ansg%3D%3D, PID: 20069688
-
Guo J, Shang EX, Duan JA, Tang Y, Qian D, Su S. Fast and automated characterization of major constituents in rat biofluid after oral administration of Abelmoschus manihot extract using ultra-performance liquid chromatography/quadrupole time-offlight mass spectrometry and MetaboLynx. Rapid Commun Mass Spectrom 2010;24:443–453.
-
(2010)
Rapid Commun Mass Spectrom
, vol.24
, pp. 443-453
-
-
Guo, J.1
Shang, E.X.2
Duan, J.A.3
Tang, Y.4
Qian, D.5
Su, S.6
-
16
-
-
84903273979
-
Huangkui Capsule-based therapy in the treatment of 20 patients with IgA nephropathy
-
Song GZ, Lian YG. Huangkui Capsule-based therapy in the treatment of 20 patients with IgA nephropathy. J New Chin Med (Chin) 2005;37:78.
-
(2005)
J New Chin Med (Chin)
, vol.37
, pp. 78
-
-
Song, G.Z.1
Lian, Y.G.2
-
17
-
-
84903271349
-
The effect of Huangkui Capsule on serum SOD, MDA, ET, NO, and urinary protein in patients with chronic kidney disease
-
Zhang QD, Qu ZS. The effect of Huangkui Capsule on serum SOD, MDA, ET, NO, and urinary protein in patients with chronic kidney disease. Chin J Integr Tradit West Nephrol (Chin) 2010;11:544–545.
-
(2010)
Chin J Integr Tradit West Nephrol (Chin)
, vol.11
, pp. 544-545
-
-
Zhang, Q.D.1
Qu, Z.S.2
-
18
-
-
84903270384
-
Observation of effects of Huangkui Capsule in the treatment of chronic glomerulonephritis with proteinuria
-
Zhu KY, Bi CY. Observation of effects of Huangkui Capsule in the treatment of chronic glomerulonephritis with proteinuria. China Pract Med (Chin) 2010;5:122–123.
-
(2010)
China Pract Med (Chin)
, vol.5
, pp. 122-123
-
-
Zhu, K.Y.1
Bi, C.Y.2
-
19
-
-
84903277993
-
Observation of effect of Huangkui Capsule combined with valsartan in the treatment of IgA nephropathy
-
Peng T, Yang XD, Li DR, Guo L, Xia Q, Hu Z. Observation of effect of Huangkui Capsule combined with valsartan in the treatment of IgA nephropathy. Chin J Integr Tradit West Nephrol (Chin) 2010;11:723–724.
-
(2010)
Chin J Integr Tradit West Nephrol (Chin)
, vol.11
, pp. 723-724
-
-
Peng, T.1
Yang, X.D.2
Li, D.R.3
Guo, L.4
Xia, Q.5
Hu, Z.6
-
20
-
-
84962054781
-
Clinical observation and analysis of Huangkui Capsule associated with losartan in 102 patients with IgA nephropathy
-
Zhang N, Xia T. Clinical observation and analysis of Huangkui Capsule associated with losartan in 102 patients with IgA nephropathy. Chin J Integr Tradit West Nephrol (Chin) 2010;11:1108.
-
(2010)
Chin J Integr Tradit West Nephrol (Chin)
, vol.11
, pp. 1108
-
-
Zhang, N.1
Xia, T.2
-
21
-
-
84903307849
-
Clinical study of Huangkui Capsule combined with benazepril in the treatment of primary IgA nephropathy
-
Han YR, Qiu ZY. Clinical study of Huangkui Capsule combined with benazepril in the treatment of primary IgA nephropathy. Chin J Integr Tradit West Nephrol (Chin) 2010;11:998–999.
-
(2010)
Chin J Integr Tradit West Nephrol (Chin)
, vol.11
, pp. 998-999
-
-
Han, Y.R.1
Qiu, Z.Y.2
-
22
-
-
84867602377
-
Mechanisms and effects of Abelmoschus manihot preparations in treating chronic kidney disease
-
Chen P, Wan Y, Wang C, Zhao Q, Wei Q, Tu Y, et al. Mechanisms and effects of Abelmoschus manihot preparations in treating chronic kidney disease. China J Chin Mater Med (Chin) 2012;37:2252–2256.
-
(2012)
China J Chin Mater Med (Chin)
, vol.37
, pp. 2252-2256
-
-
Chen, P.1
Wan, Y.2
Wang, C.3
Zhao, Q.4
Wei, Q.5
Tu, Y.6
-
23
-
-
84930242054
-
The clinical research of Abelmoschus manihot in treatment of diabetic nephropathy
-
Liu KH, Wang L, Zhang Y. The clinical research of Abelmoschus manihot in treatment of diabetic nephropathy. Jilin Med J (Chin) 2005;26:1022–1023.
-
(2005)
Jilin Med J (Chin)
, vol.26
, pp. 1022-1023
-
-
Liu, K.H.1
Wang, L.2
Zhang, Y.3
-
24
-
-
84962127719
-
Observation of effects of Huangkui Capsule combined with telmisartan for the treatment of early diabetic nephropathy
-
Zhou BX, Bai XM. Observation of effects of Huangkui Capsule combined with telmisartan for the treatment of early diabetic nephropathy. Chin Commun Doct (Chin) 2008;10:75.
-
(2008)
Chin Commun Doct (Chin)
, vol.10
, pp. 75
-
-
Zhou, B.X.1
Bai, X.M.2
-
25
-
-
84903266504
-
The effect of Huangkui Capsule on renal tubular function in patients with diabetic nephropathy
-
Chang LL, Yang SL, Zhao XL, Zhang XS, Wu WB. The effect of Huangkui Capsule on renal tubular function in patients with diabetic nephropathy. Shandong Med J (Chin) 2009;49:56–57.
-
(2009)
Shandong Med J (Chin)
, vol.49
, pp. 56-57
-
-
Chang, L.L.1
Yang, S.L.2
Zhao, X.L.3
Zhang, X.S.4
Wu, W.B.5
-
26
-
-
84962103026
-
Clinical research of combination therapy with Abelmosehus moschatus and losartan for diabetic nephropathy
-
Li XH, Lu YM, Liang YP. Clinical research of combination therapy with Abelmosehus moschatus and losartan for diabetic nephropathy. Clin Med Engin (Chin) 2009;16:3–4.
-
(2009)
Clin Med Engin (Chin)
, vol.16
, pp. 3-4
-
-
Li, X.H.1
Lu, Y.M.2
Liang, Y.P.3
-
27
-
-
84903300192
-
The effects of Huangkui Capsule on the serum indicators of renal fibrosis in patients with clinical diabetic nephropathy
-
Su JP, Xu J, Zhai XL, Zhang X, Cheng BZ, Lu X. The effects of Huangkui Capsule on the serum indicators of renal fibrosis in patients with clinical diabetic nephropathy. Chin J Clinic (Chin) 2009;37:48–50.
-
(2009)
Chin J Clinic (Chin)
, vol.37
, pp. 48-50
-
-
Su, J.P.1
Xu, J.2
Zhai, X.L.3
Zhang, X.4
Cheng, B.Z.5
Lu, X.6
-
28
-
-
84962054806
-
Clinical observation of Huangkui Capsule combination therapy in the treatment of 32 patients with early diabetic nephropathy
-
Yang S, Liu XH. Clinical observation of Huangkui Capsule combination therapy in the treatment of 32 patients with early diabetic nephropathy. Hebei J Tradit Chin Med (Chin) 2009;31:600–602.
-
(2009)
Hebei J Tradit Chin Med (Chin)
, vol.31
, pp. 600-602
-
-
Yang, S.1
Liu, X.H.2
-
29
-
-
84903269537
-
Clinical observation of effects of Huangkui Capsule combined with valsartan for the treatment of diabetic nephropathy
-
Cai XY, Huang BY, Wang YF, Chen ZP, Lin M. Clinical observation of effects of Huangkui Capsule combined with valsartan for the treatment of diabetic nephropathy. Contemp Med (Chin) 2010;16:153–154.
-
(2010)
Contemp Med (Chin)
, vol.16
, pp. 153-154
-
-
Cai, X.Y.1
Huang, B.Y.2
Wang, Y.F.3
Chen, Z.P.4
Lin, M.5
-
30
-
-
84930251229
-
Clinical research of effect of Huangkui Capsule combined with telmisartan in the treatment of diabetic nephropathy (a report of 52 cases)
-
COI: 1:CAS:528:DC%2BC3cXhtlGhtrvO
-
Chen Y. Clinical research of effect of Huangkui Capsule combined with telmisartan in the treatment of diabetic nephropathy (a report of 52 cases). J Xianning Univ (Med Sci, Chin) 2010;24:411–412.
-
(2010)
J Xianning Univ (Med Sci, Chin)
, vol.24
, pp. 411-412
-
-
Chen, Y.1
-
31
-
-
84930241925
-
Clinical observation of the effect of Huangkui Capsule combined with valsartan in the treatment of 40 patients with early diabetic nephropathy
-
COI: 1:CAS:528:DC%2BC3cXhsFalurrK
-
He YN. Clinical observation of the effect of Huangkui Capsule combined with valsartan in the treatment of 40 patients with early diabetic nephropathy. Yunnan J Tradit Chin Med Mater Med (Chin) 2010;31:24–25.
-
(2010)
Yunnan J Tradit Chin Med Mater Med (Chin)
, vol.31
, pp. 24-25
-
-
He, Y.N.1
-
32
-
-
84962108761
-
Clinical observation of the effect of Huangkui Capsule combined with valsartan for the treatment of early proteinuria in patients with type 2 diabetes
-
Li QH, He JL. Clinical observation of the effect of Huangkui Capsule combined with valsartan for the treatment of early proteinuria in patients with type 2 diabetes. Chin J Integr Tradit West Nephrol (Chin) 2010;11:142–143.
-
(2010)
Chin J Integr Tradit West Nephrol (Chin)
, vol.11
, pp. 142-143
-
-
Li, Q.H.1
He, J.L.2
-
33
-
-
84938946662
-
Observation of the effect of Huangkui Capsule on diabetic nephropathy and the underlining mechanism
-
Liu H, Zhong LY, Li RH. Observation of the effect of Huangkui Capsule on diabetic nephropathy and the underlining mechanism. Chin J Integr Tradit West Nephrol (Chin) 2010;11:633–634.
-
(2010)
Chin J Integr Tradit West Nephrol (Chin)
, vol.11
, pp. 633-634
-
-
Liu, H.1
Zhong, L.Y.2
Li, R.H.3
-
34
-
-
84903310893
-
Clinical observation of Abelmoschus manihot combined with glutathione for the treatment of diabetic nephropathy
-
Shan JP, Ye YX. Clinical observation of Abelmoschus manihot combined with glutathione for the treatment of diabetic nephropathy. Chin J Gerontol (Chin) 2010;30:2374–2375.
-
(2010)
Chin J Gerontol (Chin)
, vol.30
, pp. 2374-2375
-
-
Shan, J.P.1
Ye, Y.X.2
-
35
-
-
84903274912
-
Observation of effect of Huangkui Capsule on early and mid-stage diabetic nephropathy
-
Shen LL, Shen Y, Fang XX, Qiu ZL. Observation of effect of Huangkui Capsule on early and mid-stage diabetic nephropathy. Shandong Med J (Chin) 2010;50:59–60.
-
(2010)
Shandong Med J (Chin)
, vol.50
, pp. 59-60
-
-
Shen, L.L.1
Shen, Y.2
Fang, X.X.3
Qiu, Z.L.4
-
36
-
-
84962101219
-
The efficacy of combination of Huangkui Capsule and Salvia miltiorrhiza and Ligustrazine on diabetic nephropathy
-
Su Y, Zhang DC, Zhong S. The efficacy of combination of Huangkui Capsule and Salvia miltiorrhiza and Ligustrazine on diabetic nephropathy. Chin J Integr Tradit West Nephrol (Chin) 2010;11:1112.
-
(2010)
Chin J Integr Tradit West Nephrol (Chin)
, vol.11
, pp. 1112
-
-
Su, Y.1
Zhang, D.C.2
Zhong, S.3
-
37
-
-
84962108765
-
Observation of effect of Huangkui Capsule combined with valsartan in the treatment of diabetic nephropathy
-
Wang XC, Gao F. Observation of effect of Huangkui Capsule combined with valsartan in the treatment of diabetic nephropathy. J Hebei Med Univ (Chin) 2010;31:733–734.
-
(2010)
J Hebei Med Univ (Chin)
, vol.31
, pp. 733-734
-
-
Wang, X.C.1
Gao, F.2
-
38
-
-
84962098492
-
Effects of Okra Capsule combined with valsartan in treatment of early diabetic nephropathy with microalbuminuria
-
Xiao ZZ, Sun HJ. Effects of Okra Capsule combined with valsartan in treatment of early diabetic nephropathy with microalbuminuria. Modern J Integr Tradit Chin West Med (Chin) 2010;19:263–264.
-
(2010)
Modern J Integr Tradit Chin West Med (Chin)
, vol.19
, pp. 263-264
-
-
Xiao, Z.Z.1
Sun, H.J.2
-
39
-
-
84962069696
-
Clinical observation of Huangkui Capsule combined with telmisartan in the treatment of early diabetic nephropathy
-
Shen XH, Wang H, Xu SX, Tao J. Clinical observation of Huangkui Capsule combined with telmisartan in the treatment of early diabetic nephropathy. Med Inform (Chin) 2011;15:228–229.
-
(2011)
Med Inform (Chin)
, vol.15
, pp. 228-229
-
-
Shen, X.H.1
Wang, H.2
Xu, S.X.3
Tao, J.4
-
40
-
-
84962084526
-
The clinical research of Okra in treatment of diabetic nephropathy
-
Zhu YZ. The clinical research of Okra in treatment of diabetic nephropathy. World Health Digest (Chin) 2009;6:74–75.
-
(2009)
World Health Digest (Chin)
, vol.6
, pp. 74-75
-
-
Zhu, Y.Z.1
-
41
-
-
84962096890
-
Clinical observation of Huangkui Capsule combined with candesartan in the treatment of type 2 diabetic nephropathy
-
Yu ZW, Wang JZ, Zhang LP, Sheng XY, Zhang W, Qiu ZY, et al. Clinical observation of Huangkui Capsule combined with candesartan in the treatment of type 2 diabetic nephropathy. J Pract Diabetol (Chin) 2011;7:41–42.
-
(2011)
J Pract Diabetol (Chin)
, vol.7
, pp. 41-42
-
-
Yu, Z.W.1
Wang, J.Z.2
Zhang, L.P.3
Sheng, X.Y.4
Zhang, W.5
Qiu, Z.Y.6
-
42
-
-
84903305393
-
Observation of effect of Abelmoschus manihot combined with alprostadil in the treatment of diabetic nephropathy stage IV
-
Ding LP, Li XM, Xu C, Zhuo L, Ding M. Observation of effect of Abelmoschus manihot combined with alprostadil in the treatment of diabetic nephropathy stage IV. Chin J Misdiagnost (Chin) 2011;11:6370–6371.
-
(2011)
Chin J Misdiagnost (Chin)
, vol.11
, pp. 6370-6371
-
-
Ding, L.P.1
Li, X.M.2
Xu, C.3
Zhuo, L.4
Ding, M.5
-
43
-
-
84962045763
-
Observation of effect of Huangkui Capsule combination therapy in 31 patients with early diabetic nephropathy
-
Li ZF, Qiu GP, Peng R. Observation of effect of Huangkui Capsule combination therapy in 31 patients with early diabetic nephropathy. Jiujiang Med J (Chin) 2009;24:17–19.
-
(2009)
Jiujiang Med J (Chin)
, vol.24
, pp. 17-19
-
-
Li, Z.F.1
Qiu, G.P.2
Peng, R.3
-
44
-
-
84930240876
-
Clinical observation of effect of Huangkui Capsule combined with fosinopril for the treatment of IV stage diabetic nephropathy
-
Li HY, Xiang F, Wang Q, Li SF. Clinical observation of effect of Huangkui Capsule combined with fosinopril for the treatment of IV stage diabetic nephropathy. Pract J Card Cerebr Pneum Vascul Dis (Chin) 2009;17:691–692.
-
(2009)
Pract J Card Cerebr Pneum Vascul Dis (Chin)
, vol.17
, pp. 691-692
-
-
Li, H.Y.1
Xiang, F.2
Wang, Q.3
Li, S.F.4
-
45
-
-
84930264472
-
Clinical observation of the effects of Abelmoschus manihot combined with angiotensin-converting enzyme inhibitor in the treatment of diabetic nephropathy
-
Guan ZX, Zhang WH. Clinical observation of the effects of Abelmoschus manihot combined with angiotensin-converting enzyme inhibitor in the treatment of diabetic nephropathy. J Pract Med Techniq (Chin) 2008;15:4670–4671.
-
(2008)
J Pract Med Techniq (Chin)
, vol.15
, pp. 4670-4671
-
-
Guan, Z.X.1
Zhang, W.H.2
-
46
-
-
84930247134
-
Huangkui Capsule combined with lotensin in the treatment of 30 patients with diabetic nephropathy
-
Li YL. Huangkui Capsule combined with lotensin in the treatment of 30 patients with diabetic nephropathy. Shaanxi J Tradit Chin Med (Chin) 2007;28:562–563.
-
(2007)
Shaanxi J Tradit Chin Med (Chin)
, vol.28
, pp. 562-563
-
-
Li, Y.L.1
-
47
-
-
0029301243
-
Clinical observation on diabetic nephropathy treated with alcohol of Abelmoschus manihot
-
COI: 1:STN:280:DyaK2MzmslyhsA%3D%3D
-
Yu JY, Xiong NN, Guo HF, Deng Y. Clinical observation on diabetic nephropathy treated with alcohol of Abelmoschus manihot. Chin J Integr Tradit West Med (Chin) 1995;15:263–265.
-
(1995)
Chin J Integr Tradit West Med (Chin)
, vol.15
, pp. 263-265
-
-
Yu, J.Y.1
Xiong, N.N.2
Guo, H.F.3
Deng, Y.4
-
48
-
-
80052307183
-
Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]
-
Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration 2011.
-
(2011)
The Cochrane Collaboration
-
-
Higgins, J.P.T.1
Green, S.2
-
49
-
-
84903310892
-
The efficacy and saftey of Abelmoschus manihot (a traditional Chinese medicine) for chronic kidney disease: a systematic review and meta-analysis of observational studies (FP-373)
-
Chen Y, Gong Z, Chen X, Wei R, Tang L, Zhou J, et al. The efficacy and saftey of Abelmoschus manihot (a traditional Chinese medicine) for chronic kidney disease: a systematic review and meta-analysis of observational studies (FP-373). Poster presented at: 49th European Renal Association-European Dialysis and Transplant Association Congress, 24–27 May 2012, Paris, France. Available at: http://www.postersessiononline.com/173580348_eu/congresos/49era/aula/-FP_373_49era.pdf.
-
(2012)
Poster presented at: 49th European Renal Association-European Dialysis and Transplant Association Congress
, pp. 24-27
-
-
Chen, Y.1
Gong, Z.2
Chen, X.3
Wei, R.4
Tang, L.5
Zhou, J.6
-
50
-
-
65449155104
-
Simultaneous determination of seven active flavonols in the flowers of Abelmoschus manihot by HPLC
-
COI: 1:CAS:528:DC%2BD1MXjt12ltr8%3D, PID: 19298707
-
Lai X, Liang H, Zhao Y, Wang B. Simultaneous determination of seven active flavonols in the flowers of Abelmoschus manihot by HPLC. J Chromatogr Sci 2009;47:206–210.
-
(2009)
J Chromatogr Sci
, vol.47
, pp. 206-210
-
-
Lai, X.1
Liang, H.2
Zhao, Y.3
Wang, B.4
-
51
-
-
34249728390
-
SPE-HPLC method for the determination of four flavonols in rat plasma and urine after oral administration of Abelmoschus manihot extract
-
COI: 1:CAS:528:DC%2BD2sXmtVGntLg%3D, PID: 17258944
-
Lai X, Zhao Y, Liang H, Bai Y, Wang B, Guo D. SPE-HPLC method for the determination of four flavonols in rat plasma and urine after oral administration of Abelmoschus manihot extract. J Chromatogr B Analyt Technol Biomed Life Sci 2007;852:108–114.
-
(2007)
J Chromatogr B Analyt Technol Biomed Life Sci
, vol.852
, pp. 108-114
-
-
Lai, X.1
Zhao, Y.2
Liang, H.3
Bai, Y.4
Wang, B.5
Guo, D.6
-
52
-
-
68949116773
-
Metabolism of hibifolin by human intestinal bacteria
-
COI: 1:CAS:528:DC%2BD1MXlt1yitbg%3D, PID: 19235125
-
Xu TT, Yang XW, Wang B, Xu W, Zhao YY, Zhang QY. Metabolism of hibifolin by human intestinal bacteria. Planta Med 2009;75:483–487.
-
(2009)
Planta Med
, vol.75
, pp. 483-487
-
-
Xu, T.T.1
Yang, X.W.2
Wang, B.3
Xu, W.4
Zhao, Y.Y.5
Zhang, Q.Y.6
-
53
-
-
82955213052
-
Screening for in vitro metabolites of Abelmoschus manihot extract in intestinal bacteria by ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry
-
COI: 1:CAS:528:DC%2BC3MXhsFOgtLrP, PID: 22119023
-
Xue C, Jiang S, Guo J, Qian D, Duan JA, Shang E. Screening for in vitro metabolites of Abelmoschus manihot extract in intestinal bacteria by ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2011;879:3901–3908.
-
(2011)
J Chromatogr B Analyt Technol Biomed Life Sci
, vol.879
, pp. 3901-3908
-
-
Xue, C.1
Jiang, S.2
Guo, J.3
Qian, D.4
Duan, J.A.5
Shang, E.6
-
54
-
-
79451469487
-
Identification of the potential active components of Abelmoschus manihot in rat blood and kidney tissue by microdialysis combined with ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry
-
COI: 1:CAS:528:DC%2BC3MXhsFygsr8%3D, PID: 21247814
-
Xue C, Guo J, Qian D, Duan JA, Shang E, Shu Y, et al. Identification of the potential active components of Abelmoschus manihot in rat blood and kidney tissue by microdialysis combined with ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2011;879:317–325.
-
(2011)
J Chromatogr B Analyt Technol Biomed Life Sci
, vol.879
, pp. 317-325
-
-
Xue, C.1
Guo, J.2
Qian, D.3
Duan, J.A.4
Shang, E.5
Shu, Y.6
-
55
-
-
84860557758
-
Pretreatment with the total flavone glycosides of Flos Abelmoschus manihot and hyperoside prevents glomerular podocyte apoptosis in streptozotocin-induced diabetic nephropathy
-
Zhou L, An XF, Teng SC, Liu JS, Shang WB, Zhang AH, et al. Pretreatment with the total flavone glycosides of Flos Abelmoschus manihot and hyperoside prevents glomerular podocyte apoptosis in streptozotocin-induced diabetic nephropathy. J Med Food 2012;55:461–468.
-
(2012)
J Med Food
, vol.55
, pp. 461-468
-
-
Zhou, L.1
An, X.F.2
Teng, S.C.3
Liu, J.S.4
Shang, W.B.5
Zhang, A.H.6
-
56
-
-
84875021454
-
Effects of Huangkui Capsule on renal inflammatory injury by intervening p38MAPK signaling pathway in rats with adriamycin-induced nephropathy
-
Zhao Q, Wan YG, Sun W, Wang CJ, Wei QX, Chen HL, et al. Effects of Huangkui Capsule on renal inflammatory injury by intervening p38MAPK signaling pathway in rats with adriamycin-induced nephropathy. China J Chin Mater Med (Chin) 2012;37:2926–2934.
-
(2012)
China J Chin Mater Med (Chin)
, vol.37
, pp. 2926-2934
-
-
Zhao, Q.1
Wan, Y.G.2
Sun, W.3
Wang, C.J.4
Wei, Q.X.5
Chen, H.L.6
-
57
-
-
33748090675
-
A modified test for smallstudy effects in meta-analyses of controlled trials with binary endpoints
-
PID: 16345038
-
Harbord RM, Egger M, Sterne JA. A modified test for smallstudy effects in meta-analyses of controlled trials with binary endpoints. Stat Med 2006;25:3443–3457.
-
(2006)
Stat Med
, vol.25
, pp. 3443-3457
-
-
Harbord, R.M.1
Egger, M.2
Sterne, J.A.3
-
58
-
-
68949105690
-
Updated tests for smallstudy effects in meta-analyses
-
Harbord RM, Harris RJ, Sterne JAC. Updated tests for smallstudy effects in meta-analyses. Stata J 2009;9:197–210.
-
(2009)
Stata J
, vol.9
, pp. 197-210
-
-
Harbord, R.M.1
Harris, R.J.2
Sterne, J.A.C.3
|